Why low-cost ketamine is still inaccessible to many with severe depression | The George Institute for Global Health
Open link in next tab
Why low-cost ketamine is still inaccessible to many with severe depression | The George Institute for Global Health
https://www.georgeinstitute.org.au/media-releases/why-low-cost-ketamine-is-still-inaccessible-to-many-with-severe-depression
A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.